A comprehensive review of the peer-reviewed scientific literature finds that MDMA and psilocybin are the 2 schedule I controlled substances with a growing body of evidence supporting their efficacy and safety as medication adjuncts to facilitate manualized psychotherapy for specific disorders (PTSD for MDMA and treatment resistant major depressive disorder and end of life related […]
Read more →Magic Mushrooms legalizations efforts are happing across the United States, and at the Federal Level. The only thing that Democrats and Republicans seem to agree on these days is the medicinal properties of magic mushrooms. Both sides argue that psilocybin therapy has shown promise in helping patients with conditions such as anxiety, depression, and addiction. […]
Read more →